Does the Recent 9.9% Pullback Make CorMedix a Bargain in 2025? [Yahoo! Finance]
CorMedix Inc. (CRMD)
NASDAQ:AMEX Investor Relations:
cormedix.com
Company Research
Source: Yahoo! Finance
Many investors are taking a fresh look at the stock's true worth. After a stellar 157.2% return over the last three years, shares have pulled back in the last week by 9.9%. Year-to-date performance remains strong at 21.4%. Some of this recent movement follows notable headlines. CorMedix has made strides with its flagship DefenCath product, particularly as regulatory milestones and commercial supply updates hit the news. Investor sentiment seems to be responding both to pipeline progress and industry signals, sparking debate about what's next. All told, CorMedix earns a 5 out of 6 on our valuation checks, suggesting pockets of undervaluation. Let's dig into what those checks reveal, and stick around for a closer look at how to go beyond basic numbers to get the full valuation picture. Find out why CorMedix's -8.5% return over the last year is lagging behind its peers. Approach 1: CorMedix Discounted Cash Flow (DCF) Analysis The Discounted Cash Flow (DCF) model estimates wha
Show less
Read more
Impact Snapshot
Event Time:
CRMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRMD alerts
High impacting CorMedix Inc. news events
Weekly update
A roundup of the hottest topics
CRMD
News
- Assessing CorMedix (CRMD): Is the Current Share Price Reflecting Its True Value? [Yahoo! Finance]Yahoo! Finance
- Cormedix Inc (CRMD) Q3 2025 Earnings Call Highlights: Record Financial Performance and ... [Yahoo! Finance]Yahoo! Finance
- Buy Rating Reaffirmed: CorMedix Inc. (CRMD) Posts Profitability and Expands Outlook for 2025 [Yahoo! Finance]Yahoo! Finance
- H.C. Wainwright Raises the PT on ?CorMedix Inc. (CRMD), Keeps a Buy [Yahoo! Finance]Yahoo! Finance
- CorMedix: Raised Guidance, NOL Confidence, And Rezzayo Optionality Justify A Hold Rating [Seeking Alpha]Seeking Alpha
CRMD
Earnings
- 11/12/25 - Beat
CRMD
Sec Filings
- 12/4/25 - Form 4
- 12/1/25 - Form SCHEDULE
- 11/26/25 - Form 4
- CRMD's page on the SEC website